SOLICITATION NOTICE
A -- Neurohistology, imaging and image analysis of human mini brain pieces
- Notice Date
- 2/3/2020 6:31:21 PM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIDA ROCKVILLE MD 20852 USA
- ZIP Code
- 20852
- Solicitation Number
- HHS-NIH-NIDA-NOI-20-002142
- Response Due
- 2/18/2020 8:00:00 AM
- Archive Date
- 02/19/2020
- Point of Contact
- Kim Stapleton
- E-Mail Address
-
kim.stapleton@nih.gov
(kim.stapleton@nih.gov)
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The solicitation number is HHS-NIH-NIDA-NOI-20-002142 and the solicitation is issued as a Request for Quotation (RFQ). The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS) intends to negotiate and make an award without providing for full and open competition (Including brand-name) to Neuroscience Associates, Inc.at 10915 Lake Ridge Dr, �Knoxville, TN, 37934-4919 for neurohistology, imaging and image analysis of human mini brain pieces. NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541714 with a Size Standard of 1,000 employees. 511210; 541519; 511210; 423430; REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses of the Federal acquisition Regulation (FAR) in effect through the Federal Acquisition Circular (FAC) 2020-04 was released 1/15/2020. STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13�Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and FAR Part 12�Acquisition of Commercial Items and is not expected to exceed the simplified acquisition threshold. The provision at FAR clause 52.212-1, Instructions to Offerors � Commercial Items, applies to this acquisition. The provision at FAR clause 52.212-2, Evaluation � Commercial Items, applies to this acquisition. a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. Technical and past performance, when combined, are significantly more important than cost or price. b) Options: N/A c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer�s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. � The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications�Commercial Items, with its offer. � The FAR clause at 52.212-4, Contract Terms and Conditions � Commercial Items, applies to this acquisition. The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices. There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. DESCRIPTION OF REQUIREMENT Project Description: This requirement is to put in place a contract to conduct an exploratory study for the National Institutes of Health (NIH) Helping to End Addiction Long-term (HEAL) initiative for the National Center for Advancing Translational Sciences (NCATS) Therapeutic Development Branch (TDB) program. The main goal will be to characterize minibrains by different neuronal marker and identify differentiation stages of 3D brain models to test future opioid medications in these models. Purpose and Objectives: The TDB biology group is requesting a service to conduct an exploratory study for characterizing 3d minibrain models. The main goal will be to find differentiation and maturation stages of these minibrains for future drug testing. If it is confirmed, the program will move ahead with additional work to study opioid effects. Period of Performance: The period of performance is for two (2) months with a start date of March 30, 2020. CLOSING STATEMENT This synopsis is not a request for competitive proposals.� However, interested parties may identify their interest and capability to respond to this notice.� Responses to this solicitation must include clear and convincing evidence of the offeror�s capability of fulfilling the requirement as it relates to the technical evaluation criteria.� The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. In addition, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.� A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.� The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.�� All responses must be received by February 18, 2020 at 11:00 am Eastern Standard Time and must reference number HHS-NIH-NIDA-NOI-20-002142. Responses must be submitted electronically to kim.stapleton@nih.gov and valerie.whipple@nih.gov and must reference the solicitation number HHS-NIH-NIDA-NOI-20-002142, on your electronic request.� FAX requests are not accepted.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/f6b11e342f1d4c999b7b059cecab858c/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN05550017-F 20200205/200203230142 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |